GLP-1 Therapies and Mortality Risk: Implications for Life Insurers

Journal of insurance medicine (New York, N.Y.) · Published 2026-06-16 · DOI 10.17849/insm-53-2-1-7.1

Authors (2)

Gina C. Guzman, Tristan Walsh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Guzman, G., Walsh, T. (2026). GLP-1 Therapies and Mortality Risk: Implications for Life Insurers. Journal of insurance medicine (New York, N.Y.). https://doi.org/10.17849/insm-53-2-1-7.1

Related articles